drugset / Trial / NCT06232785

Gynecologic Endoscopic Surgery of Female Motion Sickness Patients

NCT06232785

Phase 4 Completed 66 enrolled Second Hospital of Jilin University
RandomizedParallel-groupDouble-blindPrevention

Summary

The goal of this clinical trial is to compare the analgesic effect of sufentanil and ibuprofen and the incidence of vomiting, and to choose better postoperative analgesic drugs for motion sickness patients.in describe participant population. The main questions it aims to answer are: * Whether this anesthesia method can meet the analgesic needs of gynecological laparoscopic surgery. * Whether this anesthesia method can reduce the incidence of nausea and vomiting in patients with motion sickness after gynecological laparoscopic surgery. Participants will use target-controlled infusion anesthesia combined with 0.8g ibuprofen injection. Researchers will compare with use of target-controlled infusion combined with sufentanil to see if the incidence of nausea and vomiting is higher.

Timeline

Start
2022-02-01
Primary completion
2023-10-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 0.8 g Intravenous
Comparator Sufentanil Other / unclassified 0.2 ug/kg Intravenous

Indications